{"id":"W4393165834","doi":"10.1016/j.esmoop.2024.102582","title":"3MO Amivantamab plus chemotherapy vs chemotherapy in EGFR-mutant advanced NSCLC after progression on osimertinib: A post-progression analysis of MARIPOSA-2","year":2024,"lang":"en","type":"article","venue":"ESMO Open","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; McGill University; Institute of Cancer Research; Montreal General Hospital; BC Cancer Agency","funders":"Janssen Biotech","keywords":"Osimertinib; Chemotherapy; Oncology; Medicine; Internal medicine; Epidermal growth factor receptor; Cancer; Erlotinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002023269,0.0002837773,0.0006976119,0.000505948,0.00005594771,0.00008943173,0.0002203633,0.0001282623,0.001140042],"category_scores_gemma":[0.00002152903,0.0001945168,0.0002313517,0.001275746,0.00006527432,0.0002219332,0.00007785612,0.0002090606,0.00002989649],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003839533,"about_ca_system_score_gemma":0.0003311941,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004730482,"about_ca_topic_score_gemma":0.0002034508,"domain_scores_codex":[0.9981631,0.0000571353,0.0004768493,0.0005916144,0.0003996659,0.0003116141],"domain_scores_gemma":[0.9990666,0.00007020382,0.0001321396,0.0005092515,0.00009742974,0.0001243545],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02775106,0.00233216,0.04524812,0.0003361658,0.005210171,0.0007078269,0.007806708,0.0001442931,0.01070839,0.0002392063,0.000721304,0.8987946],"study_design_scores_gemma":[0.02488092,0.005159409,0.848433,0.007239604,0.003617722,0.00003212738,0.000726519,0.008798874,0.06611458,0.0001671525,0.03401309,0.0008169594],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9835349,0.001392989,0.00005969385,0.00757992,0.0002217496,0.002561742,0.00007964582,0.00009733412,0.004471969],"genre_scores_gemma":[0.9940458,0.0003687327,0.001891116,0.001611276,0.00005129336,0.0004793579,0.0002594376,0.00006528368,0.001227688],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8979777,"threshold_uncertainty_score":0.999773,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01046002646336001,"score_gpt":0.3808748102738199,"score_spread":0.3704147838104598,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}